Fjarde Ap Fonden Boston Scientific Corp Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Boston Scientific Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 274,358 shares of BSX stock, worth $25 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

274,358

Previous 258,058 6.32%

Holding current value

$25 Million

Previous $17.7 Million 30.08%

% of portfolio

0.23%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$72.96 - $84.0 $1.19 Million - $1.37 Million	16,300 Added 6.32%	274,358 $23 Million
Q1 2024 Apr 25, 2024	BUY	$57.6 - $68.62 $708,480 - $844,026	12,300 Added 5.0%	258,058 $17.7 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $229,629 - $272,921	-4,721 Reduced 1.88%	245,758 $14.2 Million
Q3 2023 Oct 23, 2023	SELL	$50.19 - $54.68 $441,672 - $481,184	-8,800 Reduced 3.39%	250,479 $13.2 Million
Q2 2023 Aug 02, 2023	SELL	$49.72 - $54.64 $2.79 Million - $3.07 Million	-56,200 Reduced 17.81%	259,279 $14 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $798,093 - $885,531	-17,700 Reduced 5.31%	315,479 $15.8 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $1.38 Million - $1.65 Million	35,000 Added 11.74%	333,179 $15.4 Million
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $3.58 Million - $4.79 Million	-101,600 Reduced 25.41%	298,179 $11.1 Million
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $1.55 Million - $1.71 Million	-37,806 Reduced 8.64%	399,779 $17.7 Million
Q4 2021 Feb 15, 2022	SELL	$38.07 - $44.87 $315,981 - $372,421	-8,300 Reduced 1.86%	437,585 $18.6 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $614,327 - $683,612	-14,900 Reduced 3.23%	445,885 $19.3 Million
Q2 2021 Aug 12, 2021	SELL	$38.58 - $44.24 $1.18 Million - $1.36 Million	-30,700 Reduced 6.25%	460,785 $19.7 Million
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $370,335 - $416,535	10,500 Added 2.18%	491,485 $19 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $1.74 Million - $2.2 Million	52,500 Added 12.25%	480,985 $17.3 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $1.07 Million - $1.31 Million	31,000 Added 7.8%	428,485 $16.4 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $507,192 - $657,048	16,800 Added 4.41%	397,485 $14 Million
Q1 2020 May 11, 2020	SELL	$25.83 - $45.71 $351,288 - $621,656	-13,600 Reduced 3.45%	380,685 $12.4 Million
Q4 2019 Feb 10, 2020	BUY	$37.87 - $45.37 $526,393 - $630,643	13,900 Added 3.65%	394,285 $17.8 Million
Q3 2019 Oct 31, 2019	SELL	$40.31 - $43.45 $251,373 - $270,954	-6,236 Reduced 1.61%	380,385 $15.5 Million
Q2 2019 Jul 17, 2019	SELL	$34.91 - $42.98 $998,425 - $1.23 Million	-28,600 Reduced 6.89%	386,621 $16.6 Million
Q1 2019 Apr 29, 2019	BUY	$32.91 - $40.75 $2.66 Million - $3.29 Million	80,825 Added 24.17%	415,221 $15.9 Million
Q4 2018 Jan 31, 2019	SELL	$31.73 - $39.04 $1.23 Million - $1.51 Million	-38,800 Reduced 10.4%	334,396 $11.8 Million
Q3 2018 Nov 09, 2018	SELL	$32.83 - $38.63 $420,847 - $495,197	-12,819 Reduced 3.32%	373,196 $14.4 Million
Q2 2018 Jul 12, 2018	BUY	$26.84 - $34.32 $277,123 - $354,354	10,325 Added 2.75%	386,015 $12.6 Million
Q1 2018 May 07, 2018	SELL	$25.2 - $28.54 $165,866 - $187,850	-6,582 Reduced 1.72%	375,690 $10.3 Million
Q4 2017 Feb 12, 2018	BUY	$24.79 - $29.8 $1.52 Million - $1.83 Million	61,460 Added 19.16%	382,272 $9.48 Million
Q3 2017 Nov 07, 2017	BUY	$26.26 - $29.17 $7,746 - $8,605	295 Added 0.09%	320,812 $9.36 Million
Q2 2017 Aug 08, 2017	BUY	N/A	320,517	320,517 $8.89 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account